Phase II trial of DA-1241 for diabetes and dyslipidemia
Latest Information Update: 15 Feb 2021
At a glance
- Drugs DA 1241 (Primary)
- Indications Diabetes mellitus; Dyslipidaemias
- Focus Therapeutic Use
- 15 Feb 2021 New trial record
Latest Information Update: 15 Feb 2021